Bristol Myers Stock Options Expiring on 15th of August

BMY Stock  USD 46.29  0.06  0.13%   
Bristol Myers' latest option contracts expiring on August 15th 2025 are carrying combined implied volatility of 0.53 with a put-to-call open interest ratio of 0.84 over 58 outstanding agreements suggesting investors are buying slightly more calls than puts on contracts expiring on August 15th 2025. The total put volume is at 3.2 K, with calls trading at the volume of 1.2 K. This yields a 2.61 put-to-call volume ratio.

Open Interest Against August 15th 2025 Option Contracts

Bristol Myers option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Bristol Myers' lending market. For example, when Bristol Myers' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Bristol Myers, he or she must hedge the risk by shorting Bristol Myers stock over its option's life.
The chart above shows Bristol Myers' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Bristol Myers' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Bristol Myers' option, there is no secondary market available for investors to trade.

Bristol Myers Maximum Pain Price Across 2025-08-15 Option Contracts

Max pain occurs when Bristol Myers' market makers reach a net positive position across all Bristol Myers' options at a strike price where option holders stand to lose the most money. By contrast, Bristol Myers' option sellers may reap the most after selling more options than buying, causing them to expire worthless.

Bristol Myers Squibb In The Money Call Balance

When Bristol Myers' strike price is surpassing the current stock price, the option contract against Bristol Myers Squibb stock is said to be in the money. When it comes to buying Bristol Myers' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Bristol Myers Squibb are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Bristol Current Options Market Mood

Bristol Myers' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Bristol Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most Bristol Myers' options investors are not very successful. Bristol Myers' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Bristol contract

Base on the Rule 16, the options market is currently suggesting that Bristol Myers Squibb will have an average daily up or down price movement of about 0.0331% per day over the life of the 2025-08-15 option contract. With Bristol Myers trading at USD 46.29, that is roughly USD 0.0153. If you think that the market is fully incorporating Bristol Myers' daily price movement you should consider buying Bristol Myers Squibb options at the current volatility level of 0.53%. But if you have an opposite viewpoint you should avoid it and even consider selling them.

Bristol Myers Option Chain

When Bristol Myers' strike price is surpassing the current stock price, the option contract against Bristol Myers Squibb stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Bristol Myers' option chain is a display of a range of information that helps investors for ways to trade options on Bristol. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Bristol. It also shows strike prices and maturity days for a Bristol Myers against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
BMY250815C00090000190.00.0 - 0.020.02Out
Call
BMY250815C000850007785.00.0 - 0.020.01Out
Call
BMY250815C0008000090580.00.0 - 0.020.02Out
Call
BMY250815C00075000306275.00.0 - 0.030.02Out
Call
BMY250815C00070000146370.00.0 - 0.20.04Out
Call
BMY250815C0006750069867.50.01 - 0.150.02Out
Call
BMY250815C00065000141465.00.0 - 0.250.05Out
Call
BMY250815C00062500104962.50.0 - 0.770.05Out
Call
BMY250815C00060000426460.00.01 - 0.070.07Out
Call
BMY250815C00057500220257.50.07 - 0.280.07Out
Call
BMY250815C00055000581355.00.12 - 0.150.14Out
Call
BMY250815C000525001379252.50.27 - 0.310.3Out
Call
BMY250815C000500001433450.00.66 - 0.680.68Out
Call
BMY250815C0004900085149.00.87 - 0.940.9Out
Call
BMY250815C0004800029848.00.69 - 1.511.27Out
Call
BMY250815C00047000324047.01.55 - 1.681.7Out
Call
BMY250815C000460008746.02.0 - 2.122.19In
Call
BMY250815C00045000129845.02.5 - 2.682.75In
Call
BMY250815C000440002244.03.15 - 3.33.7In
Call
BMY250815C0004300070843.03.85 - 4.04.0In
Call
BMY250815C00042000342.02.94 - 4.755.04In
Call
BMY250815C000410002041.05.45 - 6.76.05In
Call
BMY250815C0004000098540.05.65 - 6.456.5In
Call
BMY250815C000380003038.08.25 - 8.459.11In
Call
BMY250815C000350002335.09.65 - 13.2513.7In
Call
BMY250815C00033000533.011.45 - 15.4511.45In
Call
BMY250815C000300002230.014.4 - 18.4519.5In
Call
BMY250815C00028000228.016.45 - 20.4516.45In
Call
BMY250815C000250006525.020.55 - 22.2521.7In
 Put
BMY250815P00090000090.044.05 - 45.444.05In
 Put
BMY250815P00085000085.039.05 - 40.2539.05In
 Put
BMY250815P00080000080.034.05 - 34.8534.05In
 Put
BMY250815P00075000075.028.5 - 30.1528.5In
 Put
BMY250815P000700001370.024.1 - 24.4524.1In
 Put
BMY250815P00067500567.521.6 - 21.8521.6In
 Put
BMY250815P0006500091465.019.15 - 19.3519.15In
 Put
BMY250815P000625005962.516.2 - 18.616.45In
 Put
BMY250815P0006000085360.014.15 - 14.3514.23In
 Put
BMY250815P0005750089157.511.7 - 11.8511.5In
 Put
BMY250815P00055000129455.09.0 - 10.258.75In
 Put
BMY250815P00052500128252.56.8 - 7.96.7In
 Put
BMY250815P00050000203350.04.6 - 4.954.53In
 Put
BMY250815P0004900037549.03.85 - 5.04.01In
 Put
BMY250815P00048000100248.03.15 - 3.33.15In
 Put
BMY250815P00047000973747.02.6 - 2.712.43In
 Put
BMY250815P00046000259046.02.06 - 2.122.06Out
 Put
BMY250815P00045000819045.01.61 - 1.811.57Out
 Put
BMY250815P0004400024144.01.23 - 1.281.21Out
 Put
BMY250815P00043000321943.00.93 - 0.970.88Out
 Put
BMY250815P00042000130742.00.68 - 0.730.7Out
 Put
BMY250815P00041000533241.00.49 - 0.540.49Out
 Put
BMY250815P00040000592740.00.35 - 0.40.37Out
 Put
BMY250815P0003800044138.00.17 - 0.230.18Out
 Put
BMY250815P000350008535.00.04 - 0.530.1Out
 Put
BMY250815P0003300043133.00.0 - 0.820.2Out
 Put
BMY250815P000300006830.00.0 - 1.470.1Out
 Put
BMY250815P000280004428.00.0 - 0.10.1Out
 Put
BMY250815P00025000105525.00.01 - 0.020.01Out

Bristol Myers Selling And Marketing Expenses Over Time

   Selling And Marketing Expenses   
       Timeline  

Bristol Total Stockholder Equity

Total Stockholder Equity

15.08 Billion

At this time, Bristol Myers' Total Stockholder Equity is fairly stable compared to the past year.

Bristol Myers Corporate Directors

Michael BonneyIndependent DirectorProfile
Robert BertoliniIndependent DirectorProfile
Phyllis YaleIndependent DirectorProfile
Matthew EmmensIndependent DirectorProfile

Additional Tools for Bristol Stock Analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.